Cargando…

Oxygen Cost of Walking in Persons with Multiple Sclerosis: Disability Matters, but Why?

Background. The oxygen cost (O(2) cost) of walking is elevated in persons with MS, particularly as a function of increasing disability status. Objective. The current study examined symptomatic (i.e., fatigue, pain, anxiety, and depression) and gait (i.e., velocity, cadence, and step length) variable...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandroff, Brian M., Klaren, Rachel E., Pilutti, Lara A., Motl, Robert W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964837/
https://www.ncbi.nlm.nih.gov/pubmed/24734181
http://dx.doi.org/10.1155/2014/162765
Descripción
Sumario:Background. The oxygen cost (O(2) cost) of walking is elevated in persons with MS, particularly as a function of increasing disability status. Objective. The current study examined symptomatic (i.e., fatigue, pain, anxiety, and depression) and gait (i.e., velocity, cadence, and step length) variables that might explain why disability status is associated with O(2) cost of walking in persons with MS. Materials and Methods. 82 participants completed the Patient-Determined Disease Steps, Fatigue Severity Scale, McGill Pain Questionnaire, and Hospital Anxiety and Depression Scale and undertook 2 trials of walking on a GAITRite electronic walkway. Participants then completed a six-minute walk test with concurrent assessment of expired gases for quantifying oxygen consumption and O(2) cost of walking. Results. Disability (r = 0.55) as well as fatigue (r = 0.22), gait velocity (r = −0.62), cadence (r = −0.73), and step length (r = −0.53) were associated with the O(2) cost of walking. Cadence (β = −0.67), but not step length (β = −0.14) or fatigue (β = −0.10), explained the association between disability and the O(2) cost of walking. Conclusions. These results highlight cadence as a target of rehabilitation for increasing metabolic efficiency during walking among those with MS, particularly as a function of worsening disability.